AMANDA CHACONAS: Open Payments
NPI 1467701664 · FLAGSTAFF, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,142 in 39 payments from 13 companies in 2025. Trend: 2023 $430 · 2024 $1,274 · 2025 $1,142
Food & beverage: $1,132Education: $10
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $363 |
| EMD Serono, Inc. | 3 | $185 |
| ARGENX US, INC. | 3 | $161 |
| GENZYME CORPORATION | 3 | $128 |
| Merz Pharmaceuticals, LLC | 2 | $52 |
| Eisai Inc. | 2 | $51 |
| PFIZER INC. | 2 | $46 |
| AstraZeneca Pharmaceuticals LP | 2 | $39 |
| UCB, Inc. | 1 | $30 |
| Neurelis, Inc. | 1 | $25 |
Products named: QULIPTA, DUOPA, VYVGART, Xeomin, Leqembi, NURTEC ODT, VYVGART HYTRULO, Rystiggo.
Industry payments across AZ — which companies pay providers there.
